Hard Drugs

Saloni Dattani & Jacob Trefethen
Hard Drugs
Último episódio

10 episódios

  • Hard Drugs

    Should everyone be taking statins?

    27/02/2026 | 2h 54min
    Heart disease is the leading cause of death worldwide, but it’s also one of medicine’s biggest success stories. Since the 1950s, the risk of dying from cardiovascular disease has fallen dramatically, thanks to public health efforts, emergency care, medical innovation, and surgeries.
    In this episode, Jacob and Saloni explore the cholesterol revolution: from statins discovered in fungi to new drugs that cut LDL cholesterol by 60% and last for months, driven by breakthroughs in genetics, monoclonal antibodies, RNA therapies, and modern medicinal chemistry. They talk about how cholesterol travels through the bloodstream, how it causes atherosclerosis and heart disease, and why it took nearly a century for scientists to form the consensus that lowering cholesterol saves lives.
    Hard Drugs is a podcast from Works in Progress and Coefficient Giving about medical innovation presented by Saloni Dattani and Jacob Trefethen.
    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Chapters: 
    0:00:00 Introduction
    13:35 The decline in heart disease mortality
    31:02 Surprising facts about cholesterol
    55:40 The lipid hypothesis: 7 lines of evidence for the harms of LDL cholesterol
    1:22:15 How cholesterol works
    1:30:40 The discovery of statins
    1:48:44 Should everyone be on statins?
    1:57:10 PCSK9 drugs and beyond
    2:22:56 Summary 
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer

    Works in Progress & Coefficient Giving
    Correction: In the episode, Saloni makes an error in converting the number of heartbeats per lifetime. It is roughly 2.5 billion beats, not a trillion.
    Books
    Daniel Steinberg (2007) The Cholesterol Wars.
    Jie Jack Li (2009) Triumph of the Heart: The Story of Statins.

    Blog posts
    James Stein (2025) Lipid and lipoprotein basics series. https://jamesstein18.substack.com/p/part-i-lipid-and-lipoprotein-basics 

    Articles
    Akira Endo (2017) Discovery and Development of Statins https://doi.org/10.1177/1934578X1701200801 
    Joseph L Goldstein, Michael S Brown (2010) History of discovery: The LDL receptor. https://pmc.ncbi.nlm.nih.gov/articles/PMC2740366/ 
    Patty W. Siri-Tarino and Ronald M. Krauss (2016) The early years of lipoprotein research: from discovery to clinical application https://pubmed.ncbi.nlm.nih.gov/27474223/ 
    Eun Ji Kim and Anthony S. Wierzbicki (2020) The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease https://pubmed.ncbi.nlm.nih.gov/32537117/ 
    Patrick W. Siri-Tarino et al. (2010) Saturated fat, carbohydrate, and cardiovascular disease. https://www.pnas.org/doi/10.1073/pnas.94.9.4312
    Saloni Dattani (2025) Death rates from cardiovascular disease have fallen dramatically — what were the breakthroughs behind this? https://ourworldindata.org/cardiovascular-deaths-decline
    Cholesterol Treatment Trialists’ (CTT) Collaboration (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. https://doi.org/10.1016/S0140-6736(10)61350-5
    E. J. Mills et al. (2011) Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. https://pubmed.ncbi.nlm.nih.gov/20934984/
    Julia Brandts and Kausik K. Ray (2023) Novel and future lipid-modulating therapies for the prevention of cardiovascular disease.  https://www.nature.com/articles/s41569-023-00860-8
    Videos
    Ninja Nerd (2018) Lipoprotein metabolism https://www.youtube.com/watch?v=wQY0xpwqPfQ
  • Hard Drugs

    The first cancer vaccine

    22/12/2025 | 2h 58min
    Hepatitis B is a tiny virus that causes hundreds of thousands of deaths from liver disease and cancer each year. The vaccine against it became the first of many milestones: it was the first viral protein subunit vaccine, the first recombinant vaccine, and the first vaccine to prevent a type of cancer. 
    In this episode, Jacob and Saloni follow the trail of strange jaundice outbreaks that scientists traced to a stealthy liver virus, how scientists turned one viral surface protein into a lifesaving shot for newborns, and how it was all built upon breakthroughs in immunology.
    Hard Drugs is a new podcast from Works in Progress and Coefficient Giving about medical innovation presented by Saloni Dattani and Jacob Trefethen.

    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Chapters:
    0:00:00 Introducing the hepatitis B vaccine
    0:15:46 The mysterious trail of jaundice outbreaks
    0:28:03 How a tiny virus causes cirrhosis and liver cancer
    0:53:19 Maurice Hilleman's purified hep B vaccine
    1:17:36 Turning the hep B vaccine recombinant
    1:29:14 The impact of hep B vaccination
    1:39:27 The 19th century battle for immunology
    2:01:34 How the body makes an almost infinite number of antibodies
    2:30:57 How subunit vaccines took over
    2:45:33 Conclusion
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 
    Books:
    Paul Offit (2007) Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases
    Arthur M Silverstein (2009) A history of immunology
    Ronald W Ellis (1993) Hepatitis B Vaccines in Clinical Practice
    Sally Smith Hughes (2011) Genentech: The beginnings of biotech
    Articles:
    Timothy M. Block et al. (2016) A historical perspective on the discovery and elucidation of the hepatitis B virus https://doi.org/10.1016/j.antiviral.2016.04.012 
    Naijuan Yao et al. (2022) Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis https://doi.org/10.1111/aogs.14448
    Jill Koshiol et al. (2019) Beasley’s 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention https://pmc.ncbi.nlm.nih.gov/articles/PMC5866222/ 
    William J. McAleer et al. (1984) Human hepatitis B vaccine from recombinant yeast https://doi.org/10.1038/307178a0 
    Chunfeng Qu et al. (2014) Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial https://doi.org/10.1371/journal.pmed.1001774 
    Anthony R Rees (2020) Understanding the human antibody repertoire https://doi.org/10.1080/19420862.2020.1729683 
    Correction: Urea was mentioned as a protein, but is actually the product of a protein breakdown process, not a protein itself.
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer
    Works in Progress & Coefficient Giving
  • Hard Drugs

    The history of vaccines

    26/11/2025 | 2h 6min
    Before vaccines became routine, they were risky experiments. In this episode, Jacob and Saloni travel back to the world of smallpox, cowpox, and cow-based “vaccine farms” to see how scientists stumbled toward the first vaccines against infectious diseases: smallpox, rabies, TB, polio, and more. Through the stories of milkmaids and aristocrats, secret lab notebooks, microscopes and cell culture, they explore how trial and error turned gruesome folk practices into the science of immunization, and how it all began with a single pustule.
    Hard Drugs is a new podcast from Works in Progress and Coefficient Giving about medical innovation presented by Saloni Dattani and Jacob Trefethen.
    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 

    Books:
    Gerald Geison (1995) The private science of Louis Pasteur
    Thomas D. Brock (1998) Robert Koch: a life in medicine and bacteriology
    Mervyn Susser and Zena Stein (2009) Eras in epidemiology : the evolution of ideas
    Angela Leung (2011) Chapter: “Variolation” and vaccination in late Imperial China, ca. 1570–1911. History of vaccine development by Stanley Plotkin
    Florian Horaud (2011) Chapter: Viral vaccines and cell substrate. History of vaccine development by Stanley Plotkin
    Samuel Katz (2011) Chapter: The role of tissue culture in vaccine development. History of vaccine development by Stanley Plotkin
    Hervé Bazin (2011) Chapter: Pasteur and the birth of vaccines made in the laboratory. History of vaccine development by Stanley Plotkin

    Articles:
    Andrew Shattock et al. (2024) Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00850-X/fulltext 
    Saloni Dattani (2020) The story of Viktor Zhdanov https://worksinprogress.co/issue/the-story-of-viktor-zhdanov/
    José Esparza et al. (2020) Early smallpox vaccine manufacturing in the United States https://doi.org/10.1016/j.vaccine.2020.05.037 
    Paula Gottdenker (1979) Francesco Redi and the fly experiments https://www.jstor.org/stable/44450950 
    Donald Angus Gillies (2016) Establishing causality in medicine and Koch’s postulates
    Burt A Folkart (1993) Dr. Albert Sabin, Developer of Oral Polio Vaccine, Dies https://www.latimes.com/archives/la-xpm-1993-03-04-mn-283-story.html 
    Saloni Dattani (2025) Measles leaves children vulnerable to other diseases for years https://ourworldindata.org/measles-increases-disease-risk 
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer
    Works in Progress & Coefficient Giving
  • Hard Drugs

    Will AI solve medicine?

    29/10/2025 | 4h 34min
    Artificial intelligence is transforming how we discover and develop new medicines. But how far can it really take us? In this episode, Jacob and Saloni trace the path of drug development from discovery to testing, manufacturing, and delivery. They explore where AI could speed things up, and where it still hits the limits of biology, data, and economics. They ask what it would take, beyond algorithms, to actually cure and eradicate diseases.
    Hard Drugs is a new podcast from Works in Progress and Open Philanthropy about medical innovation presented by Saloni Dattani and Jacob Trefethen.
    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 
    Chapters:
    0:00:00 Intro
    0:09:56 Drug discovery
    1:02:20 Animal models
    1:49:09 Drug efficacy
    2:32:56 Drug safety
    2:58:29 Manufacturing and healthcare
    3:43:23 R&D funding
    4:00:56 Trust and ambition
    4:16:01 Summary
    Blogposts:
    Claus Wilke (2025) We still can’t predict much of anything in biology https://blog.genesmindsmachines.com/p/we-still-cant-predict-much-of-anything 
    Elliot Hershberg (2025) What are virtual cells? https://centuryofbio.com/p/virtual-cell 
    Jacob Trefethen (2025) Blog series. 1) What does AI progress mean for medical progress? https://blog.jacobtrefethen.com/ai-progress-medical-progress/ 2) AI will not suddenly lead to an Alzheimer’s cure https://blog.jacobtrefethen.com/ai-san-francisco/ 3) AI could help lead to an Alzheimer’s cure https://blog.jacobtrefethen.com/ai-optimism/ 
    Articles:
    Wendi Yan (2024) Discovering an antimalarial drug in Mao’s China https://www.asimov.press/p/antimalarial-drug 
    Jason Crawford (2020) Innovation is not linear https://worksinprogress.co/issue/innovation-is-not-linear/ 
    Shayla Love (2025) An ‘impossible’ disease outbreak in the Alps https://www.theatlantic.com/health/archive/2025/03/als-outbreak-montchavin-mystery/682096/ 
    Alex Telford (2024) Origins of the lab mouse https://www.asimov.press/p/lab-mouse 
    Jonathan Karr et al. (2012) A whole-cell computational model predicts phenotype from genotype https://pmc.ncbi.nlm.nih.gov/articles/PMC3413483/ 
    Wen-Wei Liao et al. (2023) A draft human pangenome reference https://www.nature.com/articles/s41586-023-05896-x 
    Per-Ola Carlsson (2025) Survival of transplanted allogeneic beta cells with no immunosuppression https://www.nejm.org/doi/pdf/10.1056/NEJMoa2503822 
    Saloni Dattani (2024) Antipsychotic medications: a timeline of innovations and remaining challenges https://ourworldindata.org/antipsychotic-medications-timeline 
    Saloni Dattani (2024) What was the Golden Age of antibiotics, and how can we spark a new one? https://ourworldindata.org/golden-age-antibiotics 
    Books:
    Sally Smith Hughes (2011) Genentech: The beginnings of biotech
    Theses:
    Alvaro Schwalb (2025). Estimating the burden of Mycobacterium tuberculosis infection and the impact of population-wide screening for tuberculosis.
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer
    Works in Progress & Open Philanthropy
    [Minor correction: Since the 1980s, malaria challenge trials no longer involve hundreds of bites; in the past, volunteers received many bites for the exposure part of the trial rather than the challenge part.]
  • Hard Drugs

    The art of protein design with AI

    15/10/2025 | 1h
    What if you could design a protein never seen in nature? In this episode, Jacob and Saloni explore how researchers are using new tools like RFDiffusion, AlphaFold, and ProteinMPNN to ‘hallucinate’ entirely novel proteins: designing them from scratch to solve problems evolution hasn’t tackled. They talk about how these technologies could transform medicine, agriculture, and materials science. Along the way, they reflect on the surprising ways AI is changing the process of science itself.
    Hard Drugs is a new podcast from Works in Progress and Open Philanthropy about medical innovation presented by Saloni Dattani and Jacob Trefethen.
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 

    Courses:
    EMBL-EBI. AlphaFold: A practical guide https://www.ebi.ac.uk/training/online/courses/alphafold/ 

    Articles:
    Tanja Kortemme (2024) De novo protein design—From new structures to programmable functions https://www.cell.com/cell/fulltext/S0092-8674(23)01402-2 
    Jie Zhu et al. (2021) Protein Assembly by Design https://pubs.acs.org/doi/10.1021/acs.chemrev.1c00308 

    Lectures:
    Rosetta Commons (2024) Diffusion models for protein structure generation (and design) https://www.youtube.com/watch?v=OEnY2yA3jy8 
    Rosetta Commons (2024) AlphaFold – ML for protein structure prediction https://www.youtube.com/watch?v=SVrn8_8aKO8 
    Rosetta Commons (2024) MPNN – ML for protein sequence design https://www.youtube.com/watch?v=6z4XmUAwdNA 
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Rachel Shu, on-site editor
    Anna Magpie, fact-checking
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer

    Works in Progress & Open Philanthropy

Mais podcasts de Saúde e fitness

Sobre Hard Drugs

Hard Drugs is a show by Saloni Dattani and Jacob Trefethen about medical innovation: how to speed it up, how to scale it up, and how to make sure lifesaving tools reach the people who need them the most. It is brought to you by Works in Progress and Coefficient Giving.
Site de podcast

Ouça Hard Drugs, Sereno - Meditação e Relaxamento e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções

Hard Drugs: Podcast do grupo

Informação legal
Aplicações
Social
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/13/2026 - 2:45:05 AM